- Home
- MYFW vs TLSI Comparison
MYFW vs TLSI Comparison
Compare MYFW & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- TLSI
- Stock Information
- Founded
- MYFW 2002
- TLSI 2010
- Country
- MYFW United States
- TLSI United States
- Employees
- MYFW N/A
- TLSI N/A
- Industry
- MYFW Major Banks
- TLSI Medical Specialities
- Sector
- MYFW Finance
- TLSI Health Care
- Exchange
- MYFW Nasdaq
- TLSI Nasdaq
- Market Cap
- MYFW 169.4M
- TLSI 166.8M
- IPO Year
- MYFW 2018
- TLSI N/A
- Fundamental
- Price
- MYFW $18.62
- TLSI $5.00
- Analyst Decision
- MYFW Buy
- TLSI Strong Buy
- Analyst Count
- MYFW 3
- TLSI 2
- Target Price
- MYFW $20.67
- TLSI $14.00
- AVG Volume (30 Days)
- MYFW 16.4K
- TLSI 64.0K
- Earning Date
- MYFW 10-17-2024
- TLSI 08-14-2024
- Dividend Yield
- MYFW N/A
- TLSI N/A
- EPS Growth
- MYFW N/A
- TLSI N/A
- EPS
- MYFW 0.36
- TLSI N/A
- Revenue
- MYFW $80,146,000.00
- TLSI $24,736,000.00
- Revenue This Year
- MYFW N/A
- TLSI $61.24
- Revenue Next Year
- MYFW $11.04
- TLSI $47.32
- P/E Ratio
- MYFW $51.58
- TLSI N/A
- Revenue Growth
- MYFW N/A
- TLSI 67.75
- 52 Week Low
- MYFW $12.84
- TLSI $3.32
- 52 Week High
- MYFW $21.15
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- MYFW 56.45
- TLSI 38.30
- Support Level
- MYFW $18.16
- TLSI $4.80
- Resistance Level
- MYFW $19.19
- TLSI $5.47
- Average True Range (ATR)
- MYFW 0.64
- TLSI 0.35
- MACD
- MYFW 0.17
- TLSI -0.05
- Stochastic Oscillator
- MYFW 74.91
- TLSI 16.82
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.